Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,241–1,250 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1241
- Medicine slug
- pralsetinib
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 0.5
- Recorded readings
15.7 hours
- Numeric value
- 15.7
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59984249-e3ff-4f97-8d7a-c1a905d604a8 (opens source in a new tab)
Pralsetinib label
Version not recorded · Effective date not recorded
Elimination The mean (±standard deviation) plasma elimination half-life (T ½ ) of pralsetinib is 15.7 hours (9.8) following single doses and 20 hours (11.7) following multiple doses of pralsetinib.
16 hours
- Numeric value
- 16
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16edd46e-28b8-f06d-e063-6394a90ae31b (opens source in a new tab)
Pralsetinib label
Version not recorded · Effective date not recorded
Elimination The mean (±standard deviation) plasma elimination half-life (T ½ ) of pralsetinib is 16 hours (10) following single doses and 20 hours (12) following multiple doses of pralsetinib.
Projected row 1242
- Medicine slug
- pralsetinib
- Compared field
- proteinBinding
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 0.5
- Recorded readings
97.1%
- Numeric value
- 97.1
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59984249-e3ff-4f97-8d7a-c1a905d604a8 (opens source in a new tab)
Pralsetinib label
Version not recorded · Effective date not recorded
Protein binding of pralsetinib is 97.1% and is independent of concentration.
97%
- Numeric value
- 97
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16edd46e-28b8-f06d-e063-6394a90ae31b (opens source in a new tab)
Pralsetinib label
Version not recorded · Effective date not recorded
Protein binding of pralsetinib is 97% and is independent of concentration.
Projected row 1243
- Medicine slug
- pralsetinib
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
303 L
- Numeric value
- 303
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59984249-e3ff-4f97-8d7a-c1a905d604a8 (opens source in a new tab)
Pralsetinib label
Version not recorded · Effective date not recorded
Distribution The mean (CV%) apparent volume of distribution (Vd/F) of pralsetinib is 303 L (68%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16edd46e-28b8-f06d-e063-6394a90ae31b (opens source in a new tab)
Pralsetinib label
Version not recorded · Effective date not recorded
Distribution The mean (CV%) apparent volume of distribution (Vd/F) of pralsetinib is 303 L (68%).
Projected row 1244
- Medicine slug
- prasugrel
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 11
- Source count
- 11
- Agreement rate
- 1
- Recorded readings
7 hours
- Numeric value
- 7
- Unit
- hours
- Source records
- 11
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 11 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd6bf899-06b7-4f52-96c5-ffc94a7288ff (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2 to 15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb78f952-69a5-1620-e053-2a95a90afe97 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2-15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c3994da-da45-43ce-9727-a842a43c5693 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2 to 15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:944c195a-de24-a44c-8baa-84b624b5ddcb (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2-15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:406cc201-89b6-43cc-9e14-a59327a5b4d8 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2 to 15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69ea2d58-5353-4222-b61f-cab976fa7e5e (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2-15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f51e64e0-f556-65d0-a876-fb709aaeefea (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2-15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5edc1ab3-5c7a-47d6-8aaa-00523c9b4c8f (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2-15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:596c923d-db8d-4b96-bf31-52186a38c30d (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2 to 15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35aa7f3e-bbd8-4eae-b61f-29d1abca2224 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2 to 15 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41a4e332-6725-4cb7-940a-8291cf56cfe4 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The active metabolite has an elimination half-life of about 7 hours (range 2-15 hours).
Projected row 1245
- Medicine slug
- prasugrel
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 11
- Source count
- 11
- Agreement rate
- 1
- Recorded readings
44 to 68 L
- Numeric value
- 44
- Unit
- L
- Source records
- 11
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 11 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd6bf899-06b7-4f52-96c5-ffc94a7288ff (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel's active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bb78f952-69a5-1620-e053-2a95a90afe97 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel’s active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c3994da-da45-43ce-9727-a842a43c5693 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel’s active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:944c195a-de24-a44c-8baa-84b624b5ddcb (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel's active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:406cc201-89b6-43cc-9e14-a59327a5b4d8 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel’s active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69ea2d58-5353-4222-b61f-cab976fa7e5e (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel's active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f51e64e0-f556-65d0-a876-fb709aaeefea (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel's active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5edc1ab3-5c7a-47d6-8aaa-00523c9b4c8f (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel's active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:596c923d-db8d-4b96-bf31-52186a38c30d (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel’s active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35aa7f3e-bbd8-4eae-b61f-29d1abca2224 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel’s active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41a4e332-6725-4cb7-940a-8291cf56cfe4 (opens source in a new tab)
Prasugrel label
Version not recorded · Effective date not recorded
The estimates of apparent volume of distribution of prasugrel’s active metabolite ranged from 44 to 68 L and the estimates of apparent clearance ranged from 112 to 166 L/hr in healthy subjects and patients with stable atherosclerosis.
Projected row 1246
- Medicine slug
- pravastatin
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 127
- Source count
- 127
- Agreement rate
- 1
- Recorded readings
17%
- Numeric value
- 17
- Unit
- %
- Source records
- 127
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 127 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97f826f0-b5c5-410c-b1f0-523873981e8d (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db0e9c21-dc25-629a-e053-2a95a90a5ac3 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:635062df-9a84-4ff8-874c-dcee581a5555 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce61f570-2564-429b-8775-157e8e32d378 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:466e2d1a-a6d6-40f8-a9f6-3e7494a34ca6 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e0655ba-b1ba-789b-e063-6294a90a0a19 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba4ac602-46fa-8386-e053-2995a90a9764 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df75b04e-3e85-9705-e053-2995a90af83f (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d5bce9c-a788-4c52-a69e-c53174b8d061 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:056475c8-59c2-469c-9175-7162065726f5 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8dbdc80d-9d8c-4e22-9108-d87a77e07a6b (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:548bdd9f-dcc6-28c7-e054-00144ff8d46c (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ed7879d-988c-1a27-e053-2995a90a0361 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01beb7e2-ba01-4f2f-8554-4a8ec0941c9f (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:70920620-37d6-4fe0-9d86-1fdffc2e6a99 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51800012-406b-4389-817f-88dd21e338d1 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b7f5c28-78fa-4625-ad69-4291500e033d (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6a3d99c-c9cc-49d9-b0f9-503770307b70 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4573c42b-6d4a-e001-e063-6294a90acea1 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f92e12bc-40c3-4afa-9190-2f4de11ec6b3 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4fad5d73-aa79-58f2-e063-6294a90af4aa (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcf46d0c-87da-4009-b238-eb5cf287c3ed (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e218ad6-5b47-4cca-81be-ebaea5795964 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76e5fdf8-bd03-4cd5-9361-e61678cb3de9 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c4b59f1-92a8-44f8-8b4c-691f35777460 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f074240e-ef6b-45f2-8c4d-cb5c0dbc81f1 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bd4a493-1f75-e33a-53fb-4e2fbc64a1eb (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2290cad1-55c3-45a0-9d50-dd149678d191 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f814fd9-7b35-67da-e053-2a91aa0a39dc (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24471777-5cd6-4c46-a5f2-a349fadc830e (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1123d56c-16f0-4f81-b56f-67b1f343ae1e (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99cc0546-bb2d-751e-edfd-1c15a1182e0c (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bdf02140-3647-498e-ba0a-f4ca920b4e90 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ba7af14-9c87-4eb0-84c9-7e895cd75fae (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abcfc343-7ac9-4fce-b368-fd05cf14b0e2 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f87016fb-4c01-4279-8cf7-59819971ca15 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4b330ce-dfb0-4e4e-9f37-482458820c66 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca7a4143-0091-4cd5-9061-cb05cc84ea4e (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebd794ba-90c3-4d81-9c45-4aa9d9454359 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:308db0cc-0deb-99b6-e063-6394a90a9b74 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97178675-3691-2d93-e053-2995a90aa5c1 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b4ef7a8-47e5-428f-91de-7307dcbb9167 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4948e795-8c33-40e2-ae85-208962daee72 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d40e473-f79a-e50e-e063-6294a90a4d9e (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6ddb6c0-d0b4-2297-e053-6294a90a83c9 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d42bd30-1f09-49f4-9ec8-31366df1b4b4 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ecd9fd1-7662-412d-99c5-13c77188748c (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6551230-fe4c-4a6e-9c19-ae9945b76db0 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:471b4dac-057d-740c-e063-6294a90af9e9 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4015f184-b57e-4d32-9cef-15c6e1cefe24 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e9d5896-0b7c-dbd4-e053-2a95a90ae2f6 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e5c8a1c-b36f-d124-e063-6394a90a6fb5 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c21d4797-d252-4073-891f-330484c5f643 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7abc1825-182d-40bc-9f7f-968e197b4246 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7f75948-2958-44c8-b52f-5e39e80cdd1f (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12943de2-c7e9-4651-89f3-fc6cb5276676 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ed7a4d1-1183-4d95-8311-6d3e58feafa8 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd76794d-de33-4886-875c-fa05b2639f84 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40aa2d36-57ce-1f48-e063-6294a90affef (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f658680-939a-4212-8a5e-a44a896dd221 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25b7276e-a69f-af63-e063-6394a90aecf2 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14390bfa-3bcb-43e1-936c-1977cb37427d (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0641def-425e-4357-a6b6-24ce00424549 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b06ed801-ddee-4f56-924a-59fcb451eae6 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7f8c679-a602-4268-81b6-962a136a4e43 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e5cfae8-20b8-1fea-e063-6394a90a4e17 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a75de063-c751-4647-bb9e-d4050c1e31fc (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63ca6179-6ae3-4f0b-bdca-50d200317921 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f9ada33-5592-4780-926d-1af49a8e064e (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:06d85243-f9df-4984-b3d3-fcd8a7c554e9 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80ddec55-6a18-4b87-8a07-6ae86ad62853 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:33c141e9-76dc-4e32-9b2a-4621f32ac4bd (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72693449-01ee-42b0-9902-566252324579 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:64ccb4b5-b77e-4b23-8c74-4685287edb4b (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d69e8af8-dbd4-43d9-8e9a-4aed3923a17c (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ded7e5e-c377-4495-a045-f1c57b90c5db (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5f611aa-9974-422e-a353-5d834a33937c (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcf45e4f-b46e-6fbb-b67a-2ff619ab1780 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8df47d82-5b09-414d-99f1-7ac4c77f7c01 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6bb60d07-0787-4d5f-8a8c-1224d5b02b2b (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:465dc828-966e-4bb4-b935-ef26583dd4e6 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7a84cc1-f6e4-40be-9e68-cf7d43bbd617 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45f0fd53-7160-4361-ba0b-3401095441c4 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6ca01de3-a0f9-4cfb-b36a-723c7c42e2a4 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9c188f7-cd6f-afac-b493-36552d86589e (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4dbaa72-7b3e-4aef-983b-90efb2b343cd (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:095ac6fd-fdfb-4207-b15d-8e93bee378c3 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce15ad07-3286-478f-9f30-1db6a45ed402 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cef5e92-26b7-435c-878f-72a05a624560 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73633a65-93b9-46dd-8f9f-d4b5c0089040 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d2b4607-0a46-4b58-9247-dc448ce258ec (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bdfb0ef-2455-4ca2-a117-ce8e26bb2dbc (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a08fa97-24c3-4a4a-a0aa-26e50cbfc52d (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54228087-7ab0-5561-e054-00144ff8d46c (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e07ad78-1059-e0ec-e063-6394a90a9bff (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f66cb1c1-5ff1-4b0b-89d0-8ecaee26b0b8 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0bb2f1e8-9405-4f06-9a33-5ba06765a8e7 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c011348-a236-47d3-bbef-3e0b956dd080 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91c5b5c8-3379-4b84-aff7-ef6cfc65fe9f (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27ba8a69-b5aa-40eb-89f7-6bf2c1fcceae (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0b1b483-1a19-4966-89b1-118ec660f203 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:db5b8821-dca8-9322-e053-2a95a90abdc3 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:daacdad5-f75d-4f9f-b623-8071f3bef91e (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d1bf7a5-bf11-47e3-afca-dcc13f2d3068 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46cdd32d-a022-4acf-ba2b-10e7877d56c6 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:678dfe58-3200-4c3d-9718-365aa47d070f (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e358f314-9cbe-46a4-9564-6bedc7ef9d59 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b900a28-f20e-49d5-98a9-5513fee0a901 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55f8cf43-bf8b-4729-9e5a-32fcc9696e02 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf6f7031-33b9-40d3-bc87-32f1b6af98f2 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99e0e848-f8f3-4b42-b880-8fbc42633948 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97123f09-b5ad-45c2-8bb7-f50566b56b08 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03e27551-b3bf-47dd-b3ec-cd9a66ace3c4 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46fdf929-c961-4dd9-8865-8eb4adaa259a (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3686a2df-51c4-4f1c-9d1e-d69207915144 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ae196a4-be3d-4cd8-9ff2-68aeb91b8678 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7194af1-6304-4e3e-88ab-0825706a3962 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b9fe7c9-791e-49a0-a005-ccf13036c365 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b00f510-c86d-46f6-b427-311a8fd14955 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88e3b5b1-8379-492b-8902-af77f87ad995 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa152ce7-6c07-4aaf-9374-932ce81d0cf9 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ef390a6-e0a0-331d-e063-6394a90a83d0 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e6d1c1e-d5f7-42ec-bcdd-8fc310acdf21 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47207487-0c6d-8da3-e063-6294a90a8aee (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93b0e546-9e0f-40d1-9b1e-082bf16400a4 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9289f9ed-b6e3-4e81-bdb8-6aedbd5288a9 (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca779f66-4b9d-41da-ad0e-e4f58db9fbac (opens source in a new tab)
Pravastatin label
Version not recorded · Effective date not recorded
Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%.
Projected row 1247
- Medicine slug
- praziquantel
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
0.8 to 1.5 hours
- Numeric value
- 0.8
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9 (opens source in a new tab)
Praziquantel label
Version not recorded · Effective date not recorded
Elimination Following oral administration of Biltricide, the elimination half-life of praziquantel in serum ranges between 0.8 to 1.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16f2b9c4-a260-4a31-bd52-e5945913246c (opens source in a new tab)
Praziquantel label
Version not recorded · Effective date not recorded
Elimination Following oral administration of praziquantel, the elimination half-life of praziquantel in serum ranges between 0.8 to 1.5 hours.
Projected row 1248
- Medicine slug
- prednisolone
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 48
- Source count
- 19
- Agreement rate
- 1
- Recorded readings
2 to 4 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 19
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 19 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0d74ae0-7b2d-4d36-9211-c76f5063b5a9 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:401f7ba6-a4a2-9ae6-e063-6394a90a4210 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:95208441-1700-5d3f-e053-2a95a90a7da2 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d8c861d-3756-4b75-aaa9-1b82cf11eb94 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f937e7-fed5-4079-bd52-5d930b34ae9f (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3253b63b-0533-6cdc-e063-6294a90aa311 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:96de9cad-2fb7-4947-87ae-4db57563a83a (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93b372f7-b811-4c15-85c4-c6dbac342cb4 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:833ba492-8823-43b4-9a91-8b28d94a740b (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:acc8badf-d9fd-4f99-a650-a149138b68b1 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c507319-8add-4952-8bea-ff77ab17088f (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7262fc84-3db2-4475-8ae4-6bec4477cb81 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:286a6032-41de-435a-b6e6-14052b66b85d (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70% to 90% protein-bound in the plasma and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1793e218-7b49-497d-879f-1020de6e6d68 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:14b7f41b-4df1-42cb-bd1b-c74b28de2670 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4c0dcbfd-2848-9bd0-e063-6394a90af5a7 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70 to 90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f87ce1ba-335e-463d-87d5-9af0206f8f61 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:93cd0ddd-1cf5-4064-9a4c-015819c0065a (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein bound in the plasma, and it is eliminated from the plasma with a half-life of 2 to 4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ec401b5-132a-4cd2-8c24-6a5c8b63c2f9 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
Prednisolone is 70-90% protein-bound in the plasma and it is eliminated from the plasma with a half-life of 2 to 4 hours.
Projected row 1249
- Medicine slug
- prednisolone
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 48
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
0.22 - 0.7 L/kg
- Numeric value
- 0.22
- Unit
- L/kg
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e379543-c4cf-4e72-953b-db15b7f0c2a1 (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
AUC 0- ∞ (ng∙hr/mL) C max (ng∙hr/mL) Mean values of 21 normal volunteers (30 mg prednisolone base equivalent) (± S.D.) (± S.D.) Pediapred Solution 2426.1 (360.0) 461.33 (77.94) Orapred ODT 2408.1 (361.5) 420.91 (78.28) Distribution: Prednisolone is 70-90% protein-bound in the plasma and the volume of distribution is reported as 0.22 - 0.7 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebbc1751-9381-4db1-89ff-ae5a2963fb2c (opens source in a new tab)
Prednisolone label
Version not recorded · Effective date not recorded
61.5) 420.91 (78.28) *Administered under fasting conditions. ** Mean values of 21 normal volunteers Distribution: Prednisolone is 70-90% protein-bound in the plasma and the volume of distribution is reported as 0.22 - 0.7 L/kg.
Projected row 1250
- Medicine slug
- prednisone
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 247
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
6.0 - 6.5 hours
- Numeric value
- 6
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:474974ac-9811-c9f5-4050-58e535351d00 (opens source in a new tab)
Prednisone label
Version not recorded · Effective date not recorded
Median T max of prednisone delayed-release tablets in 27 healthy male subjects was 6.0 - 6.5 hours compared to 2.0 hours for an immediate-release (IR) formulation.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01bdc479-1f1f-af94-837c-12e7e861321a (opens source in a new tab)
Prednisone label
Version not recorded · Effective date not recorded
Median T max of prednisone delayed-release tablets in 27 healthy male subjects was 6.0 - 6.5 hours compared to 2.0 hours for an immediate-release (IR) formulation.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:463c7cd2-c973-5c6c-e063-6394a90a09a0 (opens source in a new tab)
Prednisone label
Version not recorded · Effective date not recorded
Median T max of prednisone delayed-release tablets in 27 healthy male subjects was 6.0 - 6.5 hours compared to 2.0 hours for an immediate-release (IR) formulation.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1240Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.